Clinical Trials Browser

OTHER × Anthracyclines × Clear all

NCT07548710 2026-06-03

Study of SA+X in the Treatment of Newly Diagnosed AML

Phase 2 Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT06332508 2026-03-13

Pulsed Electromagnetic Fields (PEMFs) - A Highly Selective Breast CAncer Treatment pLatform (PASCAL)

Phase 1 Completed

Breast Neoplasms

NCT07060001 2026-03-06

Efficacy of Hypomethylating Agents vs. Intensive Chemotherapy in Acute Myeloid Leukemia Using 5hmC as a Blood-Based Minimal Residual Disease Marker

Phase 2 Not yet recruiting

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute

NCT06802757 2026-02-25

PRISM-TNBC

Phase 2 Recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT06443645 2026-02-04

SCARA-B

Breast Neoplasms, Cardiotoxicity

NCT07317778 2026-01-05

Chemotherapy With or Without Adebrelimab and T-DXh as Neoadjuvant Therapy for HR+/HER2 Low Early Stage Breast Cancer

Phase 2 Not yet recruiting

Breast Cancer Early Stage Breast Cancer (Stage 1-3)

NCT03199300 2025-12-11

InvestiCAT

Active not recruiting

Neoplasms, Second Primary

NCT06451861 2025-11-17

Randomized Study of ABC-14 Regimen Compared With "3+7" Standard Induction Therapy or AB-14 for ND AML

Phase 2 Recruiting

Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT04335669 2025-09-12

NordicTrip, a Translational Study of Preoperative Chemotherapy in TNBC

Phase 3 Active not recruiting

Pathologic Complete Response, Breast Neoplasms, Triple Negative Breast Neoplasms

NCT02521363 2025-08-22

Implantable Microdevice for In Vivo Drug Sensitivity Testing in Patients With Early Stage, HER2-Positive or Triple Negative Breast Cancer

Phase NA Completed

11 enrolled 7 charts

Breast Neoplasms

NCT04568161 2025-04-03

Effect of Anthracyclines and Cyclophosphamide on Cardiovascular Responses

Phase NA Completed

Breast Neoplasms, Cardiovascular Diseases, Cardiotoxicity

NCT02299999 2025-01-15

SAFIR02_Breast

Phase 2 Active not recruiting

Breast Neoplasms

NCT06102824 2024-11-25

ORIENTA

Phase 2 Recruiting

HER2-negative Breast Cancer

NCT06684054 2024-11-12

STFREiYTNBC

Not yet recruiting

Breast Neoplasms

NCT02679040 2023-07-03

HIST-RIC

Phase 2 Unknown

Breast Neoplasms

NCT05916755 2023-06-23

PORTRAIT

Triple Negative Breast Neoplasms

NCT02549677 2022-10-27

ELEGANT

Phase 4 Completed

Breast Neoplasms

NCT01019616 2021-11-29

Alternative Non-cross-resistant Adjuvant Chemotherapy for Operable Breast Cancer Non-response to Primary Chemotherapy

Phase 3 Unknown

Primary Breast Cancer

NCT04499118 2020-08-05

AT Versus TP as Neoadjuvant Chemotherapy in Patients With HER2-negative Early Breast Cancer

Phase 2 Unknown

Breast Neoplasms

NCT00439920 2018-10-23

GIMEMA LAL 0496: High-dose Anthracycline in the Induction Regimen for the Treatment of Adult ALL.

Phase 2 Unknown

LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03668418 2018-09-12

xenoZ

Gastrointestinal

Biliary Tract Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Liver Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

NCT00912444 2016-11-22

NATT

Phase 3 Terminated

Breast Neoplasms

NCT02084563 2016-11-08

Study of Molecular and Genetic Abnormalities in Patients With Myeloid Neoplasms

Phase 2 Completed

Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Primary Myelofibrosis

NCT02288741 2014-11-11

DSMM-II

Phase 3 Completed

Multiple Myeloma

NCT00111345 2012-05-23

Therapy-Optimization Trial for the Treatment of Acute Myeloid Leukemias (AML) in Children and Adolescents

Phase 2/3 Unknown

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Leukemia, Myeloid, Acute